Molecular biology has made a great impact on the diagnosis of mycobacterial infection, considerably reducing the delay of reporting results to clinicians (14). AccuProbe (Gen-Probe Inc./bioMérieux) was the first molecular test developed and commercialized for the rapid identification of mycobacteria from culture-positive specimens (21). Detection of 16S rRNA by a chemiluminescent species-specific probe allowed the identification of mycobacterial isolates belonging to the Mycobacterium tuberculosis complex, the Mycobacterium avium complex (MAC/MAIS) (including species-specific probes for M. avium and Mycobacterium intracellulare), Mycobacterium kansasii (29), and Mycobacterium gordonae. However, the need for rapid identification of more mycobacterial species in parallel has resulted in the development of several in-house PCRbased assays, consisting of the amplification of several conserved genes followed by the characterization of the amplicons ensured by restriction enzyme analysis or sequencing (4-6, 9, 15-17, 22-24, 28). The 16S rRNA sequence is often considered as a gold standard for bacterial identification but has demonstrated lower variability with several examples of species difficult to separate within the genus Mycobacterium (31). The 65-kDa heat shock protein gene is highly conserved in mycobacteria, with several polymorphic regions allowing its use for identification purposes. PCR restriction pattern analysis (PRA) of an hsp65 441-bp sequence has been developed, leading to catalogues of hsp65 PRA patterns (28). The digestion product separated by agarose gel electrophoresis appears as bands whose patterns are usually species specific. In addition to the hsp65 gene, the 16S-23S rRNA internal transcribed spacer (ITS) region has been shown to be more discriminative than the 16S rRNA itself (6, 9, 10). A detailed understanding of ITS data was developed for the heterogeneous MAIS group, allowing the separation and classification of species belonging to this group as sequevars, and for other mycobacteria, including the M. tuberculosis complex (11), leading to the development of a line probe assay (INNO-LiPA-MYCOBACTERIA). This assay has been the first commercial DNA probe test able to identify the most frequently isolated mycobacterial species in parallel (18,19,27,30). After amplification of the ITS, the biotinylated amplified DNA product is hybridized with 14 specific oligonucleotide probes immobilized as parallel lines on membrane strips. These include probes for the identification of strains belonging to the M. tuberculosis complex, M. kansasii (groups I, II, and III), Mycobacterium xenopi, M. gordonae, Mycobacterium chelonae (groups I, II, and III), and MAC